In case you missed it see what’s in this section
Let's Talk
Your Total Guide To lifestyle
Immune Checkpoint Inhibitors in Oncology Study Day
A hybrid oncology education study day in Manchester covering immune checkpoint inhibitors, including selection, biomarkers and toxicity management.
Immune Checkpoint Inhibitors in Oncology Study Day
A hybrid study day providing an update on immune checkpoint inhibitors (PD-1, PD-L1 and CTLA-4 inhibitors) across tumour types, including how they work, who they are for, and recognising/managing toxicity safely and effectively.
Date & time: Tuesday 24 November 2026, 9:00am – 5:00pm
Location: The Christie Institute for Cancer Education, 550 Wilmslow Road (Department 17), Manchester
Intended audience: Healthcare professionals involved in treating patients on immunotherapy, academics in cancer research, and others with an interest in this area.
Topics include:
- Immune checkpoint inhibitor selection and biomarkers
- ICIs across tumour types
- Early immune-related adverse events
- Late and long-term irAEs
- Complex and rare immune-related toxicities and management
- Combination ICI therapy
- Nursing the ICI patient and patient safety
Venue accessibility (as listed): Lift access; accessible toilet; hearing loop; ramp access; prayer room available.
BOOK NOW
Weather in Manchester
Listings





